Lone Forner
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lone Forner has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Anne Lee
1 shared publicationAnnet Schack von Brockdorff
1 shared publicationBirgitte Nauntofte
1 shared publication- Elo Andersen
Department of Oncology, Herlev Hospital, University of Copenhagen, Denmark
1 shared publication Erik C. Jansen
1 shared publicationErik Christian Jansen
1 shared publication
Latest Publications
- 1 September 2014
- Vol. 44 (3) , 163-6
Survey of referral patterns and attitudes toward hyperbaric oxygen treatment among Danish oncologists, ear, nose and throat surgeons and oral and maxillofacial surgeons.
In head and neck cancer patients with late radiation injury, hyperbaric oxygen (HBO) is used for therapeutic or prophylactic reasons against soft-tissue and osteoradionecrosis (ORN). Twenty-nine departments of oncology, ENT, oral and maxillofacial (OMF) surgery were surveyed using the Enalyzer tool (www.enalyzer.com), of whom 21 responded. Data were incomplete in four returns. Within the previous year, 14 departments had referred at least one patient for hyperbaric oxygen therapy (HBOT). There appears to be a generally positive attitude in Danish OMF, ENT and oncology departments towards referral of patients with ORN for HBOT. However, there is an increasing desire for better evidence for its role in head and neck cancer in the prevention and treatment of soft-tissue injury and osteonecrosis following radiotherapy.
- 1 September 2014
- Vol. 44 (3) , 163-6
Survey of referral patterns and attitudes toward hyperbaric oxygen treatment among Danish oncologists, ear, nose and throat surgeons and oral and maxillofacial surgeons.
In head and neck cancer patients with late radiation injury, hyperbaric oxygen (HBO) is used for therapeutic or prophylactic reasons against soft-tissue and osteoradionecrosis (ORN). Twenty-nine departments of oncology, ENT, oral and maxillofacial (OMF) surgery were surveyed using the Enalyzer tool (www.enalyzer.com), of whom 21 responded. Data were incomplete in four returns. Within the previous year, 14 departments had referred at least one patient for hyperbaric oxygen therapy (HBOT). There appears to be a generally positive attitude in Danish OMF, ENT and oncology departments towards referral of patients with ORN for HBOT. However, there is an increasing desire for better evidence for its role in head and neck cancer in the prevention and treatment of soft-tissue injury and osteonecrosis following radiotherapy.
- 1 June 2011
- Published by Elsevier in Oral Oncology
- Vol. 47 (6) , 546-551
Does hyperbaric oxygen treatment have the potential to increase salivary flow rate and reduce xerostomia in previously irradiated head and neck cancer patients? A pilot study
- 1 June 2011
- Published by Elsevier in Oral Oncology
- Vol. 47 (6) , 546-551
Does hyperbaric oxygen treatment have the potential to increase salivary flow rate and reduce xerostomia in previously irradiated head and neck cancer patients? A pilot study